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Cytokines induced in skin by ultraviolet radiation
cause local and systemic immunosuppression. Tumor
necrosis factor a, interleukin-1, and interleukin-10 are
key mediators in the mouse, but less is known about
cytokine synthesis and function in ultraviolet-irradi-
ated human skin. We exposed human skin to 3 minimal
erythema doses of solar-simulated radiation and raised
suction blisters at intervals to 72 h. Alloantigen
presentation was suppressed in a mixed epidermal cell-
lymphocyte reaction by 69% from 4 to 15 h post-
solar-simulated radiation, but recovered to control
values by 24 h. Tumor necrosis factor a was raised at 4 h
after solar-simulated radiation, reached a maximum
8-fold increase at 15 h, then rapidly declined to control
values. Interleukin-1a and interleukin-1b were first
increased at 15 h, and remained raised to 72 h, although
interleukin-1b declined from its 15 h maximum.
Interleukin-10 increased a maximum 2-fold between
15 and 24 h, coincident with recovery of mixed epi-
Excessive ultraviolet radiation (UVR), particularly UVB(280–320 nm), initiates inflammation, local andsystemic immunosuppression, and skin cancer. Substan-tial evidence, primarily from animal models, suggeststhat UVR-induced cytokines are key mediators of
these interrelated effects (Ullrich, 1995).
UVB depletes and alters the morphology of Langerhans cells in
skin. Hapten application to Langerhans cell-depleted skin shows
impaired induction of contact hypersensitivity, and results in
tolerance (Toews et al, 1980). In mice, susceptibility to UVR
suppression of hapten sensitization is genetically determined by
polymorphism at the Tnfα and Lps loci, which regulate transcrip-
tional and translational control of tumor necrosis factor α (TNF-α)
production (Kurimoto and Streilein, 1994). Use of UVR-resistant
and UVR-susceptible mouse strains, in conjunction with adminis-
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dermal cell-lymphocyte reaction responses and down-
regulation of tumor necrosis factor a and interleukin-
1b. Solar-simulated radiation differentially affected
soluble tumor necrosis factor a receptors; soluble
tumor necrosis factor-RI was suppressed 33% at 8–15 h
whereas soluble tumor necrosis factor-RII increased
2-fold from 15 to 48 h. Interleukin-1 receptor antagon-
ist was raised at all times post-irradiation. Interleukin-
12 was not detectable in control or irradiated skin.
These kinetics suggest the tumor necrosis factor a
network has primary importance in ultraviolet-dam-
aged human skin. The small increase in interleukin-
10 implies that 3 minimal erythema doses of solar-
simulated radiation is the threshold dose for its induc-
tion and local, rather than systemic, functions for
interleukin-10 in immunosuppression and regulation
of other cytokines. Keywords: interleukin-12/immunosup-
pression/mixed epidermal cell-lymphocyte reaction/solar-
simulated radiation/sunburn. J Invest Dermatol 112:692–
698, 1999
tration of TNF-α and anti-TNF-α blocking antibodies, provided
evidence for TNF-α mediating local UVR suppression of contact
hypersensitivity (Streilein et al, 1994), but not tolerance (Shimizu
and Streilein, 1994). Although TNF-α mediates UVR suppression
of contact hypersensitivity, a role for other cytokines cannot be
excluded. Interleukin (IL)-1β is essential for development of contact
sensitization in the mouse (Enk et al, 1993a), and stimulates changes
in murine Langerhans cell phenotype and migration, but with
kinetics different from those of TNF-α (Cumberbatch et al, 1997).
Tolerance can arise from conversion of Langerhans cells from
immunogenic to tolerogenic cells. Irradiation of Langerhans cells
in vitro inhibits activation of Th1, but not Th2, lymphocytes (Simon
et al, 1991), and causes antigen-specific tolerance when hapten
derivatized and administered to naı¨ve mice (Cruz et al, 1989). Local
induction of tolerance correlates with the loss of Langerhans
cells and appearance of dermal, then epidermal, class II major
histocompatibility complex positive CD11b1 cells in mouse
(Hammerberg et al, 1996) and a CD361 CD11b1 CD1– macro-
phage subset in humans (Meunier et al, 1995) These cells are potent
producers of IL-10 (Kang et al, 1994) and activate CD41 suppressor-
inducer T lymphocytes (Baadsgaard et al, 1988). The suppression
of delayed type hypersensitivity in mice by supernatant containing
IL-10 from UVB-irradiated murine keratinocytes, which was
overcome by anti-IL-10 blocking antibody (Rivas and Ullrich,
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1992), further implicated IL-10 in tolerance in vivo, probably by
inhibiting activation of Th1 but not Th2 cells (Enk et al, 1993b).
Resistance of IL-10 gene-target mice lacking IL-10 expression
to UVR-mediated suppression of delayed type hypersensitivity
substantiated the role of IL-10 in UVR-induced immune suppres-
sion (Beissert et al, 1996).
In contrast to IL-10, IL-12 is an immune potentiating cytokine
with complex effects on the balance between Th1 and Th2 cells
(Trinchieri, 1997). Human keratinocytes synthesize IL-12 (Aragane
et al, 1994) and transcription is upregulated by UVB (Enk et al,
1996). IL-12 overcomes UVR-induced local immunosuppression
and tolerance in the mouse by preventing induction of suppressor
T cells (Schmitt et al, 1995).
Relatively little is known about the kinetics or relative release
of UVR-induced cytokines in human skin in vivo, although the
effects of UVR on human cells in vitro has been extensively studied.
The epidermis is thought to be the prime target for UVR as it is
generally believed that little UVB, the most biologically active
component of sunlight, penetrates into the dermis. Our recent
studies (Young et al, 1998) show that 2 MED of 300 nm UVR
induces specific DNA lesions in dermal cells and hair follicle
keratinocytes in situ in the human skin. Therefore, conclusions
based on UV irradiation of cultured keratinocytes, the most
frequently studied epidermal cell, may not reflect the actuality of
cytokine release in irradiated human skin in vivo. In addition,
virtually all in vitro studies have used non-solar UVR sources
containing biologically active UVC, which is not present in
sunlight. The wavelength dependence of cytokine release has not
been defined, but there is some evidence that it is important. For
example, UVA (320–400 nm) is more efficient than UVB in the
induction of IL-10 release by cultured human keratinocytes (Grewe
et al, 1995).
The aim of this study was to determine the relationship between
alloantigen presenting activity, assayed in a mixed epidermal cell-
lymphocyte reaction (MECLR), with the kinetics of immune
regulation and inflammatory cytokines, TNF-α, IL-1α, IL-1β,
IL-10, and IL-12, induced in human skin in vivo by solar-simulated
radiation (SSR) replicating typical environmental exposure to
UVR. Because the functional activity and interactions of many
cytokines, including TNF-α and IL-1, are regulated through
antagonists, receptor expression and soluble receptor release, we
determined the changes in sTNF-RI, sTNF-RII and IL-1 receptor
antagonist (IL-1Ra) following SSR.
MATERIALS AND METHODS
Volunteers Healthy volunteers (n 5 71) with either type I or type II
skin were recruited. Skin type was assessed by detailed interview and
questionnaire. Ages were in the range 18–49 y, median 25 y. Forty-six
were female. Each volunteer was fully informed of the procedures and
gave written consent prior to taking part in the studies, which were
approved by the Ethics Committee of St Thomas’ Hospital, London.
Skin irradiation and suction blisters SSR was generated by a 1 kW
solar simulator (Oriel, Leatherhead, U.K.) giving an even field of irradiance
(290–400 nm) of about 15 mW per cm2 on the skin surface, at 11 cm
from the source. Irradiance was determined by a double-monochromator
spectroradiometer (Bentham Instruments, Reading, U.K.) and was routinely
monitored with a wide band thermopile radiometer (Medical Physics,
Dryburn Hospital, Durham, U.K.). The spectral output of the solar
simulator, compared with the noon summer U.K. solar spectrum, normal-
ized at 320 nm, has been reported previously (Young et al, 1996).
Convolution of the SSR spectrum with the CIE action spectrum (McKinlay
and Diffey, 1987) showed that 93% of the effective erythema energy in
the SSR was induced by UVB wavelengths, 290–320 nm.
The minimal erythema dose (MEDjp) of SSR required to cause a ‘‘just
perceptible’’ erythema at 24 h on skin not previously UVR or sunlight
exposed was determined for all subjects. Areas (1 cm2) of upper buttock
skin were irradiated with a geometric series of √2 incremental doses of
SSR and the resulting erythema visually scored 24 h later. The median
MEDjp was 2.8 J per cm
2, range 1.4–5.6 J per cm2 (n 5 71). Quantitative
measurements of erythema were made in triplicate, using a reflectance
meter (Dia-Stron, Andover, U.K.) for 16 of the 71 volunteers. Three
2 3 2 cm areas of buttock skin were then irradiated with 3 MEDjp of SSR.
Suction blisters These were raised as previously described (Black et al,
1977), on the SSR-exposed and on three equivalent unirradiated sites,
using vacuum cups giving a single 10 mm diameter blister in µ3 h with
a 200 mmHg applied vacuum. The skin was gently warmed with a 250 W
infrared lamp placed 1.2 m above the skin to aid blister formation.
The skin temperature, measured with an adhesive thermometer (Boots,
Nottingham, U.K.) did not exceed 37.5°C. Exudate and blister tops were
collected at 4, 8, 15, 24, 48, or 72 h after irradiation. Each volunteer was
sampled at a single time point. Exudate from the replicate blisters on
irradiated skin or on control skin of each volunteer were pooled, centrifuged
at 13,000 3 g for 3 min and stored at –30°C until analyzed. Slightly more
exudate, measured for 68 of 71 subjects, was recovered from blisters raised
on SSR-irradiated skin compared with nonirradiated skin, 0.38 6 0.27
and 0.25 6 0.15 ml, respectively (mean 6 SD, p 5 0.006). The suction
blister top was removed and used immediately to prepare epidermal cell
suspensions for assessment of alloantigen presentation.
Assessment of alloantigen presentation by the MECLR Epidermal
cell suspensions were prepared by first incubating the blister tops in RPMI
1640 supplemented with 500 U per ml penicillin, 500 mg per ml
streptomycin (all from Flow Laboratories, Irvine, U.K.), and 25 µg per ml
amphotericin B for 25 min at 20°C, then in 0.05% trypsin with 0.02%
EDTA (Life Technologies, Paisley, U.K.) for 20 min at 37°C. The epidermis
was dispersed by gentle aspiration and filtered through 70 µm nylon mesh
to give a single cell suspension. Ten per cent heat-inactivated human AB
serum (Sigma, Poole, U.K.) was added and the cells washed twice in
RPMI and finally resuspended in RPMI 1640 supplemented with 50 U
penicillin per ml, 50 µg streptomycin per ml, 2 mM glutamine, and 10%
heat-inactivated human AB serum. Cell viability ranged from 80 to 95%
as determined by ethidium bromide/Acridine Orange staining, and was
not modified by prior UV exposure.
Peripheral blood mononuclear cells, used as responder cells, were
obtained by centrifugation of heparinized venous blood over Histopaque-
1077 (Sigma) density gradients. Epidermal cells (5 3 104) were incubated
in triplicate with 1 3 105 allogeneic mononuclear cells in 200 µl, 96 well
round-bottomed plates for 6 d at 37°C, with the addition of 37 kBq per
well [methyl-3H]thymidine (3H-TdR) (Amersham Life Sciences, Little
Chalfont, U.K.) for the final 18 h. Cells were harvested on to filter mats
and the cell-associated, trichloroacetic acid insoluble radioactivity measured
by liquid scintillation counting. Results are expressed as the mean counts
per minute (cpm) of 3H-TdR incorporated in triplicate cultures. Epidermal
cells or mononuclear cells incubated alone were used to determine
background thymidine incorporation.
Cytokine and soluble receptor analysis Commercial ELISA kits were
used to measure TNF-α, sTNF-RI, sTNF-RII, IL-1α, IL-1β, IL-1Ra,
IL-12 (R&D Systems, Abingdon, U.K.), and IL-10 (Amersham Life
Sciences) in suction blister exudate. The ‘‘high-sensitivity’’ assay systems
were used for TNF-α, detection limit 0.5 pg per ml, and IL-10, detection
limit 0.63 pg per ml. Results for TNF-α are expressed as the equivalent
NIBSC/WHO reference standard value. The manufacturers’ protocols
were followed, using supplied diluents for serum samples and appropriate
sample dilutions.
Statistics Data were analyzed with Stata statistics/data analysis software
(Stata, TX) using tests of distribution, analysis of variance and paired t test,
with the exception of data for IL-1α analyzed by Wilcoxon’s signed rank test.
RESULTS
Three MEDjp of SSR gave a maximum erythema in type I/
II skin The dose–response for SSR-induced erythema is shown
in Fig 1. The time course for SSR-induced erythema has been
published elsewhere (Young et al, 1996). Erythema onset was rapid,
reaching 73% of maximal within 4 h and a maximum at 18 h
before slowly declining, but still present at 168 h.
Alloantigen presentation was suppressed within 4 h by 3
MEDjp of SSR A single exposure of skin to 3 MEDjp of SSR
suppressed the MECLR response for all subjects tested at 4 h (n 5
8), 8 h (n 5 7), and 15 h (n 5 9) after skin irradiation (Fig 2a).
Suppression was greater than 50% for 18 of the 24 subjects. The
mean percentage suppression of the MECLR response was
69 6 23% (mean 6 SD, n 5 24) (Fig 2b). Mean MECLR
responses for epidermal cells obtained at 24, 48, and 72 h from
control and irradiated skin were similar (Fig 2b), although there
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Figure 1. Three MEDjp of SSR cause maximum erythema in type
I/II skin. Quantitative measurements of erythema were made 24 h after
irradiating skin of 16 volunteers, using a series of √2 incremental doses of
SSR in the range 1.4–15.8 J per cm2. Values for irradiated skin were
corrected by subtraction of the value for an unirradiated site. The SSR
dose giving a MEDjp was determined by visual assessment. The median
dose (n 5 16) for 1 MEDjp was 4 J per cm2. The erythema intensity is
expressed relative to the biologic dose.
Figure 2. Alloantigen presentation was suppressed for 15 h after 3
MEDjp of SSR, then recovered to normal values. (a) Subject variation
in SSR-induced changes in 3H-TdR incorporation in the MECLR; paired
data for epidermal cells from control and irradiated skin of each subject.
(b) The changes in MECLR responses after SSR, expressed relative to
unirradiated skin (mean 6 SD, n 5 number of subjects at each time).
was a wide subject variability, with SSR-induced changes in
MECLR responses ranging from a 77% suppression to a 157%
increase in response compared with unirradiated controls (Fig 2a).
A single exposure of skin to 3 MEDjp of SSR caused a rapid
but transient increase in the release of TNF-a The TNF-α
Figure 3. SSR increased TNF-a from 4 to 24 h after skin irradiation
and differentially modulated sTNF-R by downregulating sTNF-RI
at 8 and 15 h, but upregulating sTNF-RII from 15 to 48 h after
skin irradiation. Paired data for changes in TNF-α (top row), sTNF-RI
(middle row), and sTNF-RII (bottom row) in exudate from control and
irradiated skin for each subject, illustrating the intersubject reproducibility
of the SSR effect. Subject numbers at each time are as shown in Fig 4.
concentration was higher in exudate from irradiated compared
with control skin for 15 of 16 subjects at 4 h and for all subjects
at 8 and 15 h post-irradiation (Fig 3, top row). The maximum
release of TNF-α was at 15 h post-irradiation (3 MEDjp, 689 6 195;
control, 81 6 95 pg per ml; mean 6 SD, n 5 13, p , 0.001)
(Fig 4a). Although TNF-α in SSR-exposed skin remained signific-
ant raised at 24 h, with eight of nine subjects showing higher
levels in irradiated than control skin, release was substantially
downregulated compared with the 15 h post-irradiation maximum.
A single irradiation of skin with 3 MEDjp of SSR differentially
modulated release of sTNF-RI and sTNF-RII SSR reduced
the concentration of sTNF-RI in exudate by µ33% at 8–15 h,
but caused a 2-fold increase in sTNF-RII slightly later at 15–48 h
(Fig 4b, c). The early reduction in sTNF-RI was a consistent
effect, with exudate from irradiated skin of 14 of 15 subjects tested
at either 8 or 15 h containing lower concentrations of sTNF-RI
than the corresponding control sample (Fig 3, middle row). All
subjects (n 5 30) sampled from 15 to 72 h after SSR had
higher concentrations of sTNF-RII in irradiated compared with
unirradiated skin exudate (Fig 3, bottom row).
Skin exudate TNF-a is locally produced The mean TNF-α
concentration in skin exudate from control skin was 120 times
higher than that in serum of healthy subjects (Table I). In contrast
to TNF-α, sTNF-RI was only three times higher in skin exudate
than serum and sTNF-RII concentrations were similar (Table I).
Whereas sTNF-RI predominated over sTNF-RII in skin exudate,
sTNF-RII was higher in serum.
SSR-induced IL-1a and IL-1b occurred later than for TNF-a
but were sustained; IL-1Ra, however, was stimulated at all
times after SSR Neither IL-1α nor IL-1β was increased by
SSR at 4 or 8 h, when TNF-α was elevated, but at 15 h post-
irradiation IL-1α and IL-1β concentrations were higher in irradiated
skin for 12 of 18 and 11 of 11 volunteers, respectively (Fig 5, top
and middle rows). The distribution of IL-1α concentrations in
exudate from control skin sites was strongly skewed (mean 6 SD,
151 6 208; median, 63, first to third interquartile range, 26–165 pg
IL-1α per ml; n 5 65). Ten exudate from control skin contained
.300 pg IL-1α per ml. For this reason, nonparametric analysis
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Figure 4. Summary kinetics showing the early, transient increase
in TNF-a, the early reduction in sTNF-RI release, and the
later, sustained increase in sTNF-RII, in skin after 3 MEDjp of
SSR. Mean 6 SD and the number of subjects at each time for (a)
TNF-α, (b) sTNF-RI, and (c) sTNF-RII.
Table I. Concentrations (pg per ml) of TNF-a, sTNF-RI,
and sTNF-RII in skin exudates from unirradiated skin and
in serum from normal volunteers
TNFα sTNF-RI sTNF-RII
Skin exudate
Mean 6 SD 65 6 88 3595 6 953 2632 6 653
Range 1–437 625–5458 344–3858
n 57 40 42
Serum
Mean 6 SD 0.53 6 0.34 1222 6 241 2500 6 382
Range 0–1.3 857–1744 1841–3224
n 11 24 24
was used for IL-1α. Intersubject variability in control IL-1β
concentrations was substantially lower than for IL-1α (Fig 5,
middle row). The SSR-induced increase in IL-1β (mean 6 SD;
SSR 41 6 11; unirradiated 6.5 6 4.8 pg per ml) was more
pronounced than for IL-1α (medians; SSR 363; unirradiated 110 pg
per ml) at 15 h (Fig 6a, b). Both IL-1α and IL-1β, unlike TNF-α,
showed sustained increased concentrations to 72 h in irradiated
skin. IL-1Ra, assayed at four time-points, was increased after SSR
for all volunteers (Figs 5, bottom row, 6c).
Figure 5. SSR induced increased IL-1a and IL-1b from 15 to 72 h,
and increased IL-1Ra from 4 to 72 h, after skin irradiation. Paired
data for IL-1α (upper row), IL-1β (middle-row), and IL-1Ra (lower row) in
exudate from control and irradiated skin for each subject, illustrating the
intersubject reproducibility of the SSR effect and the variability in IL-1α
recovery from unirradiated skin. Subject numbers at each time are as
shown in Fig 6.
SSR caused a 2-fold increase in IL-10 release, coincident with
recovery of alloantigen presentation and downregulation of
TNF-a and IL-1b, but little or no IL-12 was released in
skin The mean IL-10 concentration in exudate from unirradiated
skin was 39 pg per ml compared with serum levels of less than
1.5 pg per ml (n 5 4). SSR induced a significant increase in IL-10
at 15 and 24 h after irradiation of skin (Fig 7) with the maximum
2-fold increase at 24 h when seven of eight subjects had higher
levels of IL-10 in exudate from SSR-exposed than unirradiated
skin. Exudate concentrations of IL-12 were below the detection
limit (,5 pg per ml) for unirradiated skin and at all times after SSR.
DISCUSSION
The collection of exudate and epidermal roofs from suction blisters
has enabled us to compare directly alloantigen presentation as an
indicator of immune function with the release kinetics of a
wide range of cytokines involved in immune suppression and
inflammation in human skin exposed in vivo to SSR. Our study
complements and places in context the data derived from in vitro
studies of UVR. Three MEDjp of SSR was an environmentally
relevant dose, readily achievable on exposure to summer sunlight
in temperate latitudes, and causing an intense erythema close to or
on the plateau of the dose–response curve, but without blistering,
in volunteers with types I/II skin. Although raising suction blisters
is a reliable and quantitative method for sampling skin of healthy
volunteers, it causes mild trauma, and for this reason we collected
paired control and irradiated skin samples from each subject. The
small increase in exudate from irradiated compared with control
skin showed no time dependency. Expressing cytokine release as
the total recovered would give higher apparent values for inflamed
skin, but our use of concentration units is the more conservative
approach.
Three MEDjp of SSR induced a rapid and substantial suppression
of alloantigen presentation in all volunteers up to 15 h after
exposure. Intradermal administration of 100 units TNF-α has been
shown to cause loss of epidermal Langerhans cells and recruitment
of CD361 macrophages (Groves et al, 1995), which are important
events in the modulation of alloantigen presentation in human
skin. The near maximum inhibition of MECLR responses within
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Figure 6. Summary kinetics showing sustained increases in IL-1a,
IL-1b, and IL-1Ra in exudate after irradiation of skin with 3 MEDjp
of SSR. Medians with first to third quartile range for IL-1α (a); mean 6 SD
for IL-1β (b) and IL-1Ra (c); n 5 number of subjects at each time.
Insufficient skin exudate remained after assay of other cytokines for
meaningful analysis of IL-1Ra for subjects in the 8 and 24 h post-
irradiation groups.
4 h but a continued rise in TNF-α to a maximum, 7.8 units per
blister, at 15 h shows that irradiated skin has a greater capacity to
produce TNF-α than required for suppression of alloantigen
presentation. The extent to which TNF-α is diluted in exudate
compared with the concentration proximal to cells in skin is
unknown, but the maximum TNF-α concentration in skin exudate
after SSR was 16-fold higher than that reported in serum after
whole body UVB irradiation (Ko¨ck et al, 1990).
We found no increase in mean MECLR responses for SSR-
treated skin compared with control skin at 24–72 h whereas Cooper
et al (1985) reported a 2.5-fold increase in alloantigen presentation
at 72 h after 4 MED of UVB, concomitant with recruitment of
IL-10 secreting CD361 macrophages (Kang et al, 1994). From 24
to 72 h after SSR, we observed variation in individual MECLR
responses, ranging from 77% suppression to a 157% increase,
compared with unirradiated skin. This observation, taken together
with a small and transient increase in IL-10 in irradiated skin,
suggests that our 3 MEDjp challenge dose was close to the threshold
for macrophage recruitment. We used 3 MEDjp of broad-band
SSR, sufficient to give a severe erythema, compared with 4
‘‘definite border’’ MED of UVB used by Cooper et al (1985). As
4 definite border MED approximates to 5.6 MEDjp, the SSR dose
we used is roughly half the biologically effective erythema dose
UV dose used by Cooper et al (1985).
There is controversy on whether human keratinocytes can (Enk
Figure 7. IL-10 showed a small, transient increase from 15 to 24 h
after 3 MEDjp of SSR. (a) Paired data for IL-10 in exudate from control
and irradiated skin, for each subject. (b) Summary kinetics of IL-10 release
in unirradiated and SSR treated skin (mean 6 SD, n 5 number of subjects
at each time).
et al, 1995; Grewe et al, 1995) or cannot (Jackson et al, 1996;
Teunissen et al, 1997) synthesize IL-10 protein. Kang et al (1994)
reported that human keratinocytes failed to secrete IL-10 but
accumulated intracellular IL-10. Our finding of higher IL-10 in
control skin exudate than serum is evidence that normal human
skin can make IL-10, although we cannot define the cellular source.
The increased IL-10 at 15–24 h after SSR was small compared
with changes in TNF-α and IL-1β but, taken together with the
recovery of MECLR responses in some individuals at 24 h, the
timing is consistent with the reported in vivo kinetics of infiltrating
IL-10-secreting DR1CD11b1 macrophages seen in UVB-irradi-
ated skin (Kang et al, 1994). Although IL-10 inhibits antigen
presentation by Langerhans cells in vitro (Enk et al, 1993b), our data
exclude IL-10 from causing the early SSR-induced suppression of
alloantigen presentation in vivo. We think it improbable that the
small increase in IL-10 we found under our irradiation conditions
could be sufficient to mediate systemic effects, and a local IL-10
function seems more likely. Our inability to detect IL-12 in exudate
(,5 pg per ml) from either control or irradiated skin indicates little
synthesis of IL-12 in human skin in vivo; at the doses of SSR we
used it seems unlikely that IL-12 significantly mediates the effects
of UVR in skin.
Increased TNF-α preceded and exceeded SSR-induced effects
on IL-1α, IL-1β, IL-10, and related products. IL-1Ra was the only
mediator other than TNF-α increased at 4 h and only IL-1β
showed an increase of similar magnitude, 6.5-fold compared with
an 8.5-fold rise for TNF-α. The high concentration of TNF-α in
control skin exudate compared with serum shows local TNF-α
synthesis in skin. In contrast to our findings that SSR-induced
TNF-α was an early event, Strickland et al (1997) reported increased
epidermal TNF-α mRNA and protein 24 h after UVB irradiation
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of skin and concluded TNF-α was a late mediator. UVB irradiated
keratinocytes in vitro show a 2-fold increased transcription and an
18-fold enhanced stability of TNF-α mRNA from 4 to 48 h
(Leverkus et al, 1998). Our data show a sharp downregulation of
TNF-α in skin in vivo between 15 and 24 h after SSR. Dermal
mast cells have been implicated as a source of TNF-α in UVB-
irradiated human (Walsh, 1995) and mouse skin.1 We previously
showed 300 nm UVR causes DNA damage in dermal cells in situ
(Young et al, 1998). Mast cell activation, as well as keratinocytes,
could account for increased TNF-α in the SSR-induced inflam-
mation.
IL-1β, but not IL-1α, is essential for contact sensitization in the
mouse (Enk et al, 1993a), causing Langerhans cell depletion in skin
and accumulation in lymph nodes by a mechanism different from
that of TNF-α (Cumberbatch et al, 1997). In SSR-inflamed human
skin, the 8–30-fold molar excess of IL-1α over IL-1β suggests that
IL-1α is the dominant IL-1 agonist, as both cytokines activate
IL-1R1. TNF-α induces IL-1α and IL-1Ra in cultured human
keratinocytes (Kutsch et al, 1993), and could initiate the increases
in IL-1 and IL-1Ra in vivo. SSR. The greater stimulation of IL-1β
than IL-1α by SSR may reflect differential regulation and cellular
sources of the IL-1 species. Although we failed to detect increased
IL-1 prior to 15 h, Murphy et al (1989), using skin abrasions, found
increased IL-1-like bioactivity within 30 min of UVB irradiation,
and which declined to control levels by 2 h.
Regulatory control of TNF-α and IL-1 is complex, involving
synthesis and processing of the agonists, cell surface expression and
function of receptors and antagonists, and release of soluble recep-
tors. IL-10 is a potent inhibitor of TNF-α and IL-1 synthesis
in vitro (Bogdan et al, 1991) and in mouse skin in vivo after
trinitrochlorobenzene sensitization (Enk et al, 1994). The sharp
downregulation we found for TNF-α in skin between 15 and 24 h
after SSR exposure could result from the increased IL-10 at these
times. The incomplete suppression of IL-1α and IL-1β may
help maintain the long-lived inflammation due to SSR (Young
et al, 1996)
TNFα acts through two receptors, TNF-RI (TNF-R55,
CD120a) and TNF-RII (TNF-R75, CD120b), which can be
cleaved from the cell surface to give soluble forms (Bazzoni and
Beutler, 1996). Cleavage desensitizes cells by reducing the surface
receptor concentrations, and competitive binding of TNF-α to
sTNF-R modulates the activity, stability, and clearance of TNF-α
(Aderka et al, 1992). The effects of UVR on sTNF-R in vivo have
not been studied. The ratio of TNF-RI to TNF-RII we found in
serum was similar to published values (Abe et al, 1994). The
3-fold higher sTNF-RI in exudate compared with serum indicates
constitutive release of sTNF-RI in normal skin. We found reduced
sTNF-RI concentrations in skin exudate in vivo after SSR, in
contrast to Trefzer et al (1993) who saw no effect of UVB
on sTNF-RI release from human keratinocytes, although UVB
modulated keratinocyte cell surface TNF-RI expression in vitro.
TNF-RII is expressed on human Langerhans cells (Ryffel et al,
1991), but not keratinocytes (Trefzer et al, 1993). In the mouse,
TNF-α-induced Langerhans cell migration is TNF-RII dependent
(Wang et al, 1996). The differential effects of SSR on sTNF-RI
and sTNF-RII may reflect changes in cell populations and/or
mechanisms of sTNF-RI and sTNF-RII cleavage from cell-surface
receptors. IL-10 inhibits TNF-α release from human monocytes
but upregulates TNF-RII expression and the release of sTNF-RII
(Joyce and Steer, 1996). Thus, the increased sTNF-RII after SSR
may be due to increased IL-10.
IL-1Ra regulates IL-1 activity by binding to, but not triggering,
IL-1R (Dripps et al, 1991). Our finding of increased in IL-1Ra in
exudate after SSR are consistent with increased IL-1Ra in the
stratum corneum of sun-exposed skin (Hirao et al, 1996). We found
1Alard P, Niizeki H, Streilein JW: Mast cells are the source of TNF-α
that impairs hypersensitivity induction after UV radiation. J Invest Dermatol
108:592, 1997 (abstr.)
a 300-fold molar excess of IL-1Ra above the sum of IL-1α and
IL-1β for both irradiated and unirradiated skin, but other studies
suggest that a considerable excess of IL-1Ra is required to inhibit
fully the IL-1 activity (Arend et al, 1990). The detection by bioassay
of increased IL-1-like activity in abraded UVB-irradiated skin
(Murphy et al, 1989) is evidence that IL-1 agonist activity predomin-
ates over IL-1Ra in skin exudate. TNF-α induces IL-1Ra and
IL-1α release from keratinocytes (Kutsch et al, 1993). The early
increase in TNF-α in irradiated skin in vivo could initiate IL-1Ra
release as part of a downregulatory mechanism in the IL-1 network.
We propose from our kinetic studies that TNF-α is the key
mediator of UV-induced damage in human skin. Changes in
sTNF-R suggests that receptor expression could extend regulatory
control of TNF-α activity. The role of IL-10 has still to be
established. The relatively small increase in IL-10 after SSR suggests
that 3 MEDjp is a threshold dose for release. A local action at
this dose seems probable but we cannot exclude that excessive
environmental exposure to sunlight, causing severe sunburn over
a large area of skin, could cause sufficient IL-10 release for a
systemic effect. The later increase in IL-1 implies a role in extending
the sunburn inflammation.
This study was supported by the European Commission (Contract No, EV5V-
CT94-0564). We thank Jacqui Nagel for assistance in volunteer recruitment and
skin irradiation.
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